Christopher Glembotski, PhD

Christopher Glembotski, PhD portrait
  • Professor, Tenure, Internal Medicine
  • Vice Dean, Research
  • Director, Translational Cardiovascular Research Center
  • Curriculum Vitae
    • Primary Address
    • Office
    • University of Arizona College of Medicine - Phoenix
    • 475 North 5th Street, Suite Room 811
    • Phoenix, AZ, United States 85004

Biography

Education

  • Postdoctoral Fellowship 1983, Molecular Physiology, University of Colorado Health Sciences Center
  • PhD 1979, Biochemistry, University of California, Los Angeles

Biography

“I moved to Phoenix to cure heart disease,” says Chris Glembotski, director of the Translational Cardiovascular Research Center at the University of Arizona College of Medicine - Phoenix.

Dr. Glembotski completed his doctoral studies at UCLA in Biochemistry, then did a post-doctoral fellowship in neuroscience and cell physiology at the University of Colorado Health Sciences Center. After which, he was on the faculty of the University of Pennsylvania Perleman School of Medicine as Professor of Pharmacology, then became Distinguished Professor and Director of the San Diego State University Heart Institute. In September of 2020, Dr. Glembotski took the position of Professor of Internal Medicine, Associate Dean for Research and inaugural Director of the Translational Cardiovascular Research Center at the College.

Dr. Glembotski has mentored more than 50 graduate students in his lab, which focuses on finding cures for heart disease by translating scientific discoveries in the research lab to treatments for patients. As the Center director, he has built a strong translational research team of faculty, medical and postdoctoral fellows, as well as graduate and medical students, who work in a vibrant, exciting environment at the College campus. As the Associate Dean for Research, Dr. Glembotski works with scientists and physicians in many fields to enhance the translational research at the College. He is dedicated to mentoring faculty, research fellows and students to help them achieve their academic and research goals in medicine and science. His hope is to improve patient treatment and outcomes and to one day to “cure heart disease."